AngioDynamics Inc. (UG2)
XSTU
13.60
+0.10 (+0.74%)
Closed
Sep 28, 2026
Day's Range
13.2013.70
52 wk Range
8.1014.00
Financial Statements - UG2 - AngioDynamics Inc.
Revenue
320.17M▲ 9.5%
Net Income
-36.74M▼ 8.1%Net Margin -11.5%
EBITDA
18.22M▲ 3.4%
Free Cash Flow
508.00K▲ 103.5%
Income Statement
| Period Ending | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 |
|---|---|---|---|---|---|---|
| Sales | 320.17M | 292.49M | 303.91M | 338.75M | 316.21M | 291.01M |
| Cost of Goods | 145.28M | 134.79M | 149.21M | 164.50M | 150.48M | 134.22M |
| Gross Profit | 174.89M | 157.70M | 154.69M | 174.24M | 165.73M | 156.78M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -22.32M | -24.06M | -33.84M | -18.67M | -18.21M | -14.96M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -13.67M | -10.94M | -159.40M | -33.05M | -11.04M | -20.22M |
| Pre Tax Income | -36.30M | -34.03M | -191.63M | -54.43M | -29.94M | -36.05M |
| Income Tax | 442K | -39K | -7.28M | -1.99M | -3.40M | -4.50M |
| Net Income | -36.74M | -33.99M | -184.34M | -52.44M | -26.54M | -31.54M |
| EPS Basic | -0.88 | -0.83 | -4.59 | -1.33 | -0.68 | -0.82 |
| EPS Diluted | -0.88 | -0.83 | -4.59 | -1.33 | -0.68 | -0.82 |
| Basic Shares Outstanding | 41.52M | 40.85M | 40.18M | 41.08M | 40.59M | 39.90M |
| Diluted Shares Outstanding | 41.52M | 40.85M | 40.18M | 41.08M | 40.59M | 39.90M |
| Ebit | -22.32M | -24.06M | -33.84M | -18.67M | -18.21M | -35.19M |
| Ebitda | 18.22M | 17.63M | 152.45M | 44.69M | 21.38M | 11.04M |
| Net Income Continuous Operations | -36.74M | -33.99M | -184.34M | -52.44M | -26.54M | -31.54M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
